5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid
CAS: 16506-27-7
Ref. 3D-FB32117
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire |
Product Information
- Bendamustine
- 1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
- 2-Benzimidazolebutyric acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
- 4-[5-[Bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
- 4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid
- 5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid
- ω-[1-Methyl-5-[bis(β-chloroethyl)amino]-2-benzimidazolyl]butyric acid
5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid (BCBA) is an experimental cancer drug that is being investigated for the treatment of a variety of cancers. BCBA inhibits the growth and proliferation of cancer cells by interfering with DNA synthesis and repair. BCBA has been shown to be effective in treating T cell lymphomas, as well as solid tumours such as carcinoma cell lines and breast cancer. The drug has also been used to treat hypersensitivity syndrome in many patients with infectious diseases.
Chemical properties
Technical inquiry about: 3D-FB32117 5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
